

See product citations (11)
QUICK LINKS
DPTA NONOate is a diazeniumdiolate small molecule nitric oxide (NO) donor with a reported NO release half-life of 5 hr (22-25degC). NO release conferred by DPTA NONOate blocked cisplatin-induced cell death in lung carcinoma H-460 cells, suggesting that the expression of Bcl-2, a primary mediator of tumor resistance to cisplatin, is regulated by NO. This mechanism of Bcl-2 regulation was elucidated with DPTA NONOate and other NO donors/inhibitors and ultimately correlated to NO-induced S-nitrosylation of the Bcl-2 protein. This, in turn, blocks the ubiqutination and subsequent proteasomal degradation of the protein. DPTA NONOate release of NO is demonstrated to attenuate the pulmonary hypertension induced by group B Streptococcus exposure.
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
DPTA NONOate, 5 mg | sc-202144 | 5 mg | $54.00 | |||
DPTA NONOate, 10 mg | sc-202144B | 10 mg | $57.00 | |||
DPTA NONOate, 25 mg | sc-202144A | 25 mg | $138.00 | |||
DPTA NONOate, 50 mg | sc-202144C | 50 mg | $204.00 | |||
DPTA NONOate, 100 mg | sc-202144D | 100 mg | $367.00 |